Prostate Cancer Trial, Recruiting NCT06509919 Sponsor: Shanghai Changzheng Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06509919
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male and between 18 and 80 years old
  • Your PSA blood test result is between 4 and 10 ng/ml (a measure of a protein linked to prostate health)
  • You are already scheduled to have a prostate biopsy, AND at least one of the following applies: a specific ratio of your PSA measurements is below a certain level, your PSA is high relative to your prostate size, your PSA has been rising quickly over time, your doctor felt something abnormal during a rectal exam, or an ultrasound or MRI scan showed a suspicious area on your prostate (confirm with trial site for exact measurements)

Who may not be able to join:

  • You have been diagnosed with any cancer in the past 5 years
  • You have previously had surgery to remove or reduce prostate tissue (such as a TURP procedure)
  • You have previously received any treatment for prostate cancer, including hormone therapy, targeted therapy, or immunotherapy
  • You regularly take blood-thinning or anti-clotting medications, or you stopped taking them less than one week ago
  • You have received any cancer treatment — including surgery, radiotherapy, chemotherapy, hormone therapy, targeted therapy, or immunotherapy — before the blood sample for this trial is taken
  • You have another serious ongoing illness (such as a severe heart, lung, nerve, mental health, digestive, hormonal, immune, or kidney condition) that the trial doctor believes could interfere with the study
  • You have had an organ transplant, or have received a bone marrow or stem cell transplant from another person
  • You received a blood transfusion within one month before your blood sample is taken
  • You are currently in another clinical trial, or finished one less than one year ago
  • The trial doctor believes, for any reason, that the trial is not appropriate for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 139 1779 3885

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Changzheng Hospital
Registry
ClinicalTrials.gov
Start date
9 July 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

AUROC value for predicting positive needle biopsy results (prostate cancer) in individuals with PSA levels in the gray zone.; Sensitivity for predicting positive needle biopsy results (prostate cancer) in individuals with PSA levels in the gray zone.; Specificity for predicting positive needle biopsy results (prostate cancer) in individuals with PSA levels in the gray zone.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov